Data / Form D filings / EMMAUS LIFE SCIENCES, INC.
EMMAUS LIFE SCIENCES, INC.: Form D filings
EMMAUS LIFE SCIENCES, INC., a pharmaceuticals company in Torrance, CA, filed 9 Form D notices with the SEC between 2011 and 2019. The latest, on April 1, 2019, reports $2.6 million sold of an offering with no set size to 7 investors.
Find out what EMMAUS LIFE SCIENCES, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 21250 HAWTHORNE BLVD., SUITE 800, Torrance, CA, 90503
- Phone
- (310) 214-0065
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1420031
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2019 | New notice | Indefinite | $2,585,000 | Indefinite | 7 | Feb 12, 2019 | sec.gov |
| Nov 1, 2018 | New notice | $12,200,000 | $12,200,000 | $0 | 18 | Oct 22, 2018 | sec.gov |
| Oct 14, 2016 | New notice | $20,000,000 | $20,000,000 | $0 | 2 | Sep 29, 2016 | sec.gov |
| Jan 20, 2016 | New notice | $40,000,000 | $1,700,000 | $38,300,000 | 0 | Jan 13, 2016 | sec.gov |
| Oct 2, 2013 | Amendment | $7,551,253 | $7,551,253 | $0 | 36 | Sep 11, 2013 | sec.gov |
| Sep 24, 2013 | New notice | $7,551,253 | $7,551,253 | $0 | 36 | Sep 11, 2013 | sec.gov |
| Oct 18, 2011 | New notice | $3,715,079 | $3,715,079 | $0 | 13 | Jun 29, 2011 | sec.gov |
| Sep 26, 2011 | New notice | Indefinite | $0 | Indefinite | 318 | May 3, 2011 | sec.gov |
| Apr 4, 2011 | New notice | $1,200,000 | $1,013,500 | $186,500 | 61 | Mar 25, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yutaka Niihara | Executive Officer, Director | |
| Kurt Kruger | Executive Officer | |
| Willis Lee | Executive Officer, Director | |
| Lan Tran | Executive Officer | |
| Yasushi Nagasaki | Executive Officer | |
| Robert Dickey | Director | |
| Masaharu Osato | Director | |
| Wei Peu Zen | Director | |
| Ian Zwicker | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Apr 1, 2019 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what EMMAUS LIFE SCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.